Sort
17,828 grants matching “crispr”
Antisense Oligonucleotide (ASO) Development for Rare and Neglected Diseases
$1,450,000Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR
CK20-004, J. Craig Venter Insitute and Cleveland VA Prevention and Intervention Epicenter
$1,448,172Derrick E Fouts · J. Craig Venter Institute, Inc. · U54 · FY2022 · CK
Functional genomic screens for molecular targets in cancer
$1,445,697Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Oncogenic mechanisms and molecular targets in lymphoma
$1,445,697Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
DEVELOPMENT OF PLX-R18 CELL THERAPY AS A COUNTERMEASURE FOR HEMATOPOIETIC ACUTE RADIATION SYNDROME
$1,445,145Chen Franco-Yehuda · Pluristem, Ltd · N01 · FY2023 · AI
Molecular Analysis Of Human Hereditary Deafness
$1,444,031Andrew J. Griffith · National Institute On Deafness And Other Communication Disorders · ZIA · FY2019 · DC
The role of Galpha13 signaling in suppression of lymphoma
$1,441,999Jagan Muppidi · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Human pluripotent stem cells
$1,440,017Pamela Robey · National Institute Of Neurological Disorders And Stroke · ZIC · FY2018 · NS
Genomic profiling of influenza infections to identify biomarkers of disease severity
$1,439,918Elodie Ghedin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Gene Therapy for Inherited Blood Disorders
$1,439,551Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Building a Systematic, Comprehensive Mammalian Cell Fate Map
$1,438,780Michelle Chan · Princeton University · DP2 · FY2022 · HD
Functionally Assessing Transcriptional Enhancers In Vivo
$1,436,554Len Alexander Pennacchio · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2023 · HG
Regulation Of Intracellular Iron Metabolism
$1,435,381Tracey A. Rouault · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD
Targeting exploitable vulnerabilities in T-cell Lymphoma
$1,434,488Samuel Ng · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Diabetes Research Center
$1,434,361Steven E Kahn · University Of Washington · P30 · FY2023 · DK
Deconvolution and interruption of the cancer-neuro-immune axis facilitating brain metastases
$1,431,221Melanie Hayden Gephart · Stanford University · U54 · FY2024 · CA
Deciphering microbial virulence mechanisms during Legionella pneumophila infection
$1,429,806Matthias Machner · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
Post genome wide association studies in testicular germ cell tumors
$1,426,684Katherine L Nathanson · University Of Pennsylvania · U01 · FY2022 · CA
Mechanisms of Therapy and Model Development in Viral Hepatitis and Liver Diseases
$1,422,712T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Methods to Rapidly Explore Combinatorial Diversity and their Application to CRISPR-Cas9 Systems
$1,422,000Alejandro Chavez · University Of California, San Diego · DP2 · FY2022 · NS
Diabetes Research Center
$1,421,361Steven E Kahn · University Of Washington · P30 · FY2025 · DK
Diabetes Research Center
$1,421,361Steven E Kahn · University Of Washington · P30 · FY2024 · DK
Functional genomic screens for molecular targets in cancer
$1,418,557Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Oncogenic mechanisms and molecular targets in lymphoma
$1,418,557Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
RP3: Targeting ATG gene-dependent immunity for novel anti-infective therapeutics
$1,418,421Seungmin Hwang · Ut Southwestern Medical Center · U19 · FY2020 · AI